Antiviral Res HEDSKOG C, Rodriguez L, Hu Y, Li J, et al SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19. Antiviral Res. 2026 Jan 19:106351. doi: 10.1016/j.antiviral.2026.106351. PubMed Abstract available BMJ HIGGS J Help me piece my story together. BMJ. 2026;392:r2624. PubMed RUSSELL MD, Schaffer A, Bechman K, Gibson M, et al Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELY. BMJ. 2026;392:e086393. PubMed Abstract available Clin Infect Dis WINOKUR P, Diya O, Fitz-Patrick D, Dever M, et al Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18?55 Years Old. Clin Infect Dis. 2026 Jan 21...
Media Monitoring for Signals about Emerging Threats